Chargement en cours...
Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
PURPOSE: Nausea and vomiting are major adverse effects of chemotherapy and can greatly impact patients’ quality of life. Although chemotherapy-induced nausea and vomiting (CINV) prevalence is high, treatment remains difficult. Palonosetron is a 5-hydroxytryptamine receptor antagonist (5-HT(3)RA) app...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435088/ https://ncbi.nlm.nih.gov/pubmed/25999723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S68130 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|